Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Rakshit Pharmaceuticals Limited, is an unlisted public company incorporated on 23 November, 2005. It is classified as a public limited company and is located in Hyderabad, Telangana. It's authorized share capital is INR 5.00 cr and the total paid-up capital is INR 4.21 cr.
Rakshit Pharmaceuticals Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has decreased by 38.46% over the previous year. At the same time, it's book networth has increased by 5.99%.
Read more
** All rupee values in INR crores. Based on March 2024 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Anjaneya Pattabhi Rameswara Rao Chandana
Shareholder
|
00105304 | 20 years |
Director | Aruna Kumari Chandana
Shareholder
|
00105360 | 20 years |
Managing Director | Palem Srinivas
Shareholder
|
01717688 | 16 years |
Director | Veera Venkata Vara Prasad Veerni | 08700919 | 5 years |
Director | Bhavani Sankar Alla | 08700926 | 5 years |
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
SVC Co-operative Bank Limited
No. of Loans: 1
Total Amount : 76.2 cr
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
SRI BHAVANA FABTECH PRIVATE LIMITED |
Active
|
2.0 L | 2 | Telangana |
SAINOR PHARMA PRIVATE LIMITED |
Amalgamated
|
3.5 Cr | 1 | Telangana |
RAKSHIT RESEARCH CENTRE PRIVATE LIMITED |
Active
|
14.4 L | 3 | Telangana |
SAINOR PHARMA PRIVATE LIMITED |
Active
|
18.0 L | 1 | Telangana |
ORGANOR CHEMICALS LLP |
Inactive for e-filing
|
3.0 L | 1 | ng |
GOLDMARGH VENTURE CAPITAL LLP |
Active
|
1.4 L | 1 | Telangana |
SRISAICHANDANA API PRIVATE LIMITED |
Active
|
7.0 Cr | 1 | Andhra Pradesh |
RAKSHIT DRUGS PRIVATE LIMITED |
Active
|
2.2 Cr | 3 | Telangana |
SAINOR LABORATORIES PRIVATE LIMITED |
Active
|
3.3 Cr | 1 | Telangana |
AZICO BIOPHORE INDIA PRIVATE LIMITED |
Active
|
8.9 Cr | 3 | Andhra Pradesh |
AZICO PHARMACEUTICALS PRIVATE LIMITED |
Active
|
14.4 L | 1 | Telangana |
NORIKAA PHARMACEUTICALS PRIVATE LIMITED |
Active
|
5.0 L | 1 | Andhra Pradesh |
BDV PHARMA SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Andhra Pradesh |
Read more
The incorporation date of RAKSHIT PHARMACEUTICALS LIMITED is 23 November, 2005
The authorized share capital of RAKSHIT PHARMACEUTICALS LIMITED is INR ₹ 5.0 Cr.
The paid-up capital of RAKSHIT PHARMACEUTICALS LIMITED is INR ₹ 4.2 Cr.
The registered address of RAKSHIT PHARMACEUTICALS LIMITED is 425/3RT, D.No, 7-1-621/328 Sanjeev Reddy Nagar HYDERABAD Telangana - 500038
The CIN number of RAKSHIT PHARMACEUTICALS LIMITED is U24239TG2005PLC048151.